Pills for the good health of pharma companies

Rohitashwa Prasad, Partner, JSA outlines the business strategies that pharma companies need to adopt for risk mitigation to deal with the impact of COVID – 19

The healthcare industry is a silver lining in the dark clouds looming over the Indian economy since the outbreak of the COVID-19 pandemic. Demand for certain kinds of drugs, devices and healthcare facilities is expected to grow significantly in the near future.

Please click here to read the full article.